Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 741 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 605 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| F Develops biotech-powered hair supplements using proprietary microencapsulation | Undisclosed | Follow-OnUndisclosed | Healthtech, Biotech | United Kingdom | Investors | |
| S StairMedCompany profile Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases | CN¥500M | StrategicUndisclosed | Healthtech | China | Investors | |
| A Develops real-time nervous system regulation tools | $1.9M | Undisclosed | Healthtech | Finland | Investors | |
| LT Long TailCompany profile Provides AI-native software for utilization management and denials workflows for health systems Provides AI-native software for utilization management and denials workflows for health systems | Undisclosed | Growth | Healthtech | United States | Investors | |
| T TimeSmartAICompany profile Provides AI-driven physician contract compliance and compensation management for healthcare systems Provides AI-driven physician contract compliance and compensation management for healthcare systems | Undisclosed | StrategicUndisclosed | Healthtech | Canada | Investors | |
| AB Ambrosia BiosciencesCompany profile Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. | $100M | Series B | Healthtech, Biotech | United States | Investors | |
| SB Develops implantable lymphatic drainage system to manage lymphedema | $1.5M | Pre-SeedPre-seed | Healthtech | United States | Investors | |
| W Provides wearable health monitoring and personalized health insights | $575M | Series GSeries C+ | Healthtech | United States | Investors 2PointZero GroupAbbott +22AccompliceAffinity PartnersB-FlexionBullhound CapitalCollaborative FundCristiano RonaldoFoundryGlade BrookIVPKaren WazenLeBron JamesMacquarie CapitalMathieu van der PoelMayo ClinicMubadala Investment CompanyNiall HoranPromus VenturesQatar Investment Authority (QIA)Reggie MillerRory McIlroyShane LowryVirgil van Dijk | |
| TB TippingPoint BiosciencesCompany profile Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5M | Seed | Healthtech, Biotech | United States | Investors | |
| S Develops next-generation cell assay technology for drug discovery | $3.8M | Undisclosed | Healthtech, Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.